GLP-1 receptor agonist
Semaglutide
Sold as Ozempic, Wegovy, Rybelsus
Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy). No generic is available — costs are high.
Compare prices →~$920.00 / mo (generic, NADAC)
What it treats
Type 2 diabetes; chronic weight management with weight-related comorbidities.
Typical dosing
Ozempic/Wegovy: weekly subcutaneous injection, titrated up. Rybelsus: daily oral tablet.
Side effects
Nausea, vomiting, diarrhea, constipation. Rare: pancreatitis, gallbladder problems, thyroid C-cell tumors (in animal studies).
Interactions to know
Slows gastric emptying — affects absorption of oral meds. Watch with insulin and sulfonylureas (hypoglycemia risk).
Pregnancy & breastfeeding
Stop at least 2 months before a planned pregnancy.
Educational only. Not medical advice. Always confirm with your prescriber or pharmacist.